Literature DB >> 29594370

Gender difference in the point prevalence, symptoms, comorbidity, and correlates of depression: findings from the Lagos State Mental Health Survey (LSMHS), Nigeria.

Abiodun O Adewuya1,2, Olurotimi A Coker3, Olayinka Atilola3, Bolanle A Ola3, Mathew P Zachariah3, Tomilola Adewumi4, Olufemi Olugbile5, Adedolapo Fasawe6, Olajide Idris6.   

Abstract

It is still unclear whether the gender difference in the rate of depression cuts across cultures or is specific to some depressive symptoms. This study evaluated the gender difference in current prevalence, symptoms, comorbidity, and correlates of depression in Lagos, Nigeria. A total of 11,246 adult participants (6525 females and 4712 males) in a face-to-face household survey were assessed for symptoms of depression. They were also assessed for symptoms of anxiety, somatic symptoms, alcohol and substance use disorders, and disability. The difference between the point prevalence for symptoms of depression in females (6.3%, s.e 0.3) and males (4.4%, s.e 0.3) was significant (OR 1.28, 95% CI 1.14-1.59). Compared to males, females had significantly higher rates for anhedonia (OR 1.20), hypersomnia (OR 2.15), fatigue (OR 1.49), guilt/worthless feeling (OR 1.41), poor concentration (OR 1.32), psychomotor retardation (OR 1.51), and suicidal ideation (OR 1.32). However, poor appetite (OR 0.69) and comorbidity with alcohol use (OR 0.25) was significantly lower in females compared to males. The significantly higher rates for depression in females were only restricted to below 45 years and higher socioeconomic status. Our study further contributed to the growing literature suggesting that the gender differences in rates of depression not only cut across many cultures, but most pronounced with atypical symptoms, not affected by recall bias and seems to disappear with increasing age. These need to be considered when formulating mental health policies for equitable and acceptable health services.

Entities:  

Keywords:  Comorbidity; Depression; Gender difference; Prevalence; Sub-Saharan Africa

Mesh:

Year:  2018        PMID: 29594370     DOI: 10.1007/s00737-018-0839-9

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  6 in total

1.  Depression and anxiety symptoms amongst kenyan adolescents: Psychometric Properties, Prevalence Rates and Associations with Psychosocial Wellbeing and Sociodemographic factors.

Authors:  Tom L Osborn; Katherine E Venturo-Conerly; Jenny Y Gan; Micaela Rodriguez; Rediet G Alemu; Elizabeth Roe; Susana G Arango; Akash R Wasil; Stephanie Campbell; John R Weisz; Christine M Wasanga
Journal:  Res Child Adolesc Psychopathol       Date:  2022-06-08

2.  Depression in Sub-Saharan Africa.

Authors:  Ismail Temitayo Gbadamosi; Isaac Tabiri Henneh; Oritoke Modupe Aluko; Emmanuel Olusola Yawson; Aliance Romain Fokoua; Awo Koomson; Joseph Torbi; Samson Ehindero Olorunnado; Folashade Susan Lewu; Yusuf Yusha'u; Salmat Temilola Keji-Taofik; Robert Peter Biney; Thomas Amatey Tagoe
Journal:  IBRO Neurosci Rep       Date:  2022-03-17

3.  Adapting culturally appropriate mental health screening tools for use among conflict-affected and other vulnerable adolescents in Nigeria.

Authors:  B N Kaiser; C Ticao; C Anoje; J Minto; J Boglosa; B A Kohrt
Journal:  Glob Ment Health (Camb)       Date:  2019-06-03

4.  A gender comparison of psychological distress among medical students in Nigeria during the Coronavirus pandemic: a cross-sectional survey.

Authors:  Oluwaseun Mercy Idowu; OyinOluwa Gloria Adaramola; Boluwatife Samson Aderounmu; Ifeoluwa Delight Olugbamigbe; Olaoluwa Ezekiel Dada; Adeyinka Christopher Osifeso; Oluseun Peter Ogunnubi; Oluwakemi Ololade Odukoya
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

5.  Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression.

Authors:  Wei Zheng; Xin-Hu Yang; Li-Mei Gu; Jian-Qiang Tan; Yan-Ling Zhou; Cheng-Yu Wang; Yu-Ping Ning
Journal:  Front Psychiatry       Date:  2022-09-16       Impact factor: 5.435

6.  Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.

Authors:  Lijuan Yuan; Xihui Chen; Ziyu Liu; Dan Wu; Jianguo Lu; Guoqiang Bao; Sijia Zhang; lIfeng Wang; Yuanming Wu
Journal:  Endocr Connect       Date:  2018-08-01       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.